Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is completed in the United States, in the United Kingdom, in Belgium, .... It is testing TAK-503 for ADHD.
Multiple locations, including DothanThis study is completed in the United States. It is testing TD-9855 for ADHD.
Multiple locations, including Bradenton
This study is completed. It focuses on ADHD and currently lists study information in the Netherlands.
In NijmegenThis study is completed in the United Kingdom. It focuses on ADHD.
In LondonThis study is completed in the United States. It is testing solriamfetol for ADHD.
Multiple locations, including EncinoThis study is completed in France, in the United Kingdom, in Switzerland, .... It is testing Effectiveness and Safety of Prolonged Release OROS Methylphenidate for ADHD.
Multiple locations, including AntwerpThis study is completed in the United States. It is testing dasotraline for ADHD.
Multiple locations, including Newport BeachThis study is completed in the United States. It is testing dasotraline for ADHD.
Multiple locations, including Newport BeachThis study is completed in the United States. It is testing SPN-810 for ADHD.
Multiple locations, including DothanThis study is completed in the United States. It is testing Two Doses of PF-03654746 for ADHD.
Multiple locations, including LafayetteThis study has public registry information in China. It is testing AK0901 for ADHD.
In BeijingThis study is completed. It focuses on ADHD and currently lists study information in South Korea.
Multiple locations, including Bucheon-Si Gyeonggi-Do